125 related articles for article (PubMed ID: 6836324)
21. [Effect of thioctic acid (alpha-limpoic acid) on the chemotherapeutic efficacy of cyclophosphamide and vincristine sulfate].
Berger M; Habs M; Schmähl D
Arzneimittelforschung; 1983; 33(9):1286-8. PubMed ID: 6416261
[TBL] [Abstract][Full Text] [Related]
22. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
Dolowy WC; Schrek R; Henson D; Cornet J; Brown E
Nature; 1968 Jun; 218(5146):1028-31. PubMed ID: 5656616
[No Abstract] [Full Text] [Related]
23. Cyclophosphamide cystitis. Studies aimed at its minimization.
Cox PJ; Abel G
Biochem Pharmacol; 1979 Dec; 28(24):3499-502. PubMed ID: 231445
[No Abstract] [Full Text] [Related]
24. Study of antitumor activity of antibodies to TNF-α on Walker carcinosarcoma model.
Yurlova EI; Krylova SG; Dugina JL; Epstein OI
Bull Exp Biol Med; 2013 Sep; 155(5):673-5. PubMed ID: 24288736
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study for the expression of Bcl-2 family proteins in Walker 256 carcinosarcoma cells under the influence of cytostatic drugs.
Ovsjanko EV; Lushnikova EL; Larionov PM; Arkhipov SA; Nepomnyashchikh LM; Efremov AV; Ovsjanko YU
Bull Exp Biol Med; 2009 Oct; 148(4):650-5. PubMed ID: 20396763
[TBL] [Abstract][Full Text] [Related]
26. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
27. [Test of multi-step-therapy of cancer (combination of pretreatment with glucose with chemotherapy and whole body hyperthermia) in Walker- and DS-carcinosarcoma of rat (author's transl)].
Heinrich M; Osswald H
Arch Geschwulstforsch; 1974; 43(4):310-9. PubMed ID: 4429424
[No Abstract] [Full Text] [Related]
28. [The effect of ferromagnet particles on the growth of Walker carcinosarcoma 256 in Wistar rats].
Volkonskiĭ VA
Eksp Onkol; 1990; 12(2):74-6. PubMed ID: 2318139
[TBL] [Abstract][Full Text] [Related]
29. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
Karaivanova MK
Eksp Med Morfol; 1974; 13(4):237-42. PubMed ID: 4219353
[No Abstract] [Full Text] [Related]
30. Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.
Volm M; Mattern J; Weber N; Wayss K
Cancer Chemother Pharmacol; 1980; 4(2):89-93. PubMed ID: 6156026
[TBL] [Abstract][Full Text] [Related]
31. [Effect of 2-ethyl-6-methyl-3-oxypyridine on the sympathetic-adrenal system of tumor carriers].
Strigun LM; Ustinovskaia TA; Iurova NN; Kozlova EN; Konovalova NP
Dokl Akad Nauk SSSR; 1984; 274(5):1266-8. PubMed ID: 6723502
[No Abstract] [Full Text] [Related]
32. Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma.
DeWys WD; Humphreys SR; Goldin A
Cancer Chemother Rep; 1968 Feb; 52(2):229-42. PubMed ID: 5646850
[No Abstract] [Full Text] [Related]
33. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
Volm M; Mattern J; Wayss K
Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of cure of large plasma cell tumors.
Whisson ME; Connors TA; Jeney A
Arch Immunol Ther Exp (Warsz); 1966; 14(6):825-31. PubMed ID: 5958003
[No Abstract] [Full Text] [Related]
35. In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals.
Gold J
Cancer Treat Rep; 1986 Dec; 70(12):1433-5. PubMed ID: 3791255
[TBL] [Abstract][Full Text] [Related]
36. [Disorders of blood rheology in Walker's carcinosarcoma-256 and in cyclophosphamide treatment of rats].
Plotnikov MB; Maslov MIu; Aliev OI; Vasil'ev AS; Zueva EP; Krylova SG; Shilova NV
Vopr Onkol; 2001; 47(3):335-7. PubMed ID: 11544834
[TBL] [Abstract][Full Text] [Related]
37. Proliferation of Walker 256 carcinosarcoma cells: effect of whole-body hyperthermia and antitumor agents.
Lushnikova EL; Ovsyanko EV; Nepomnyashchikh LM; Efremov AV; Morozov DV
Bull Exp Biol Med; 2011 Nov; 152(1):146-52. PubMed ID: 22803062
[TBL] [Abstract][Full Text] [Related]
38. Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.
Sladek NE
Cancer Res; 1973 Jun; 33(6):1150-8. PubMed ID: 4718666
[No Abstract] [Full Text] [Related]
39. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effect of GPA1734 in rat Walker 256 carcinoma.
Missirlis E; Karakiulakis G; Maragoudakis ME
Invest New Drugs; 1990 May; 8(2):145-7. PubMed ID: 2384301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
